Goldman Sachs’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,544
| Closed | -$34.4K | – | 4942 |
|
|
2024
Q2 | $34.4K | Sell |
17,544
-737
| -4% | -$1.45K | ﹤0.01% | 4583 |
|
|
2024
Q1 | $48.6K | Buy |
+18,281
| New | +$48.6K | ﹤0.01% | 4538 |
|
|
2022
Q4 | – | Sell |
-3,335
| Closed | -$29K | – | 5275 |
|
|
2022
Q3 | $29K | Buy |
3,335
+28
| +0.8% | +$243 | ﹤0.01% | 5105 |
|
|
2022
Q2 | $38K | Sell |
3,307
-200
| -6% | -$2.3K | ﹤0.01% | 5333 |
|
|
2022
Q1 | $61K | Sell |
3,507
-11,643
| -77% | -$203K | ﹤0.01% | 5427 |
|
|
2021
Q4 | $491K | Buy |
+15,150
| New | +$491K | ﹤0.01% | 4540 |
|
|
2018
Q4 | – | Sell |
-5,169
| Closed | -$403K | – | 4173 |
|
|
2018
Q3 | $403K | Buy |
+5,169
| New | +$403K | ﹤0.01% | 3534 |
|